More than a million people around the world rely on cochlear implants (CIs) to hear. CI effectiveness is generally evaluated through speech recognition tests, and despite how widespread they are, CI ...

Cochlear Limited (($CHEOF)) announced an update on their ongoing clinical study. Study Overview: Cochlear Limited is conducting a feasibility ...

Patients in the UAE living with severe hearing loss are finding new hope through advanced cochlear implant surgery performed at King’s College Hospital London in Dubai. Led by Dr Ida Laila Amir, ...

Sources familiar with the situation tell PEOPLE the former president is doing well and responding to treatment Nicholas Rice is a Senior Editor for PEOPLE Magazine. He began working with the brand as ...

Cochlear Limited (($CHEOF)) announced an update on their ongoing clinical study. Study Overview: Cochlear Limited is conducting a clinical study ...

Brown was the second university to turn down the deal, which would have given a funding preference to universities that agreed to certain requirements. By Alan Blinder Reporting from Providence, R.I.

Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...

Analysts are mixed on Pro Medicus, with 5 out of 15 recommending a buy and an average target price of $326.49, indicating a 13.76% upside. Analyst views are divided on Cochlear, with a potential 11.15 ...

The former president's office announced his prostate cancer diagnosis in May. Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

Scientists have found a potential new treatment target for Alzheimer’s. It comes after a novel technique improved cognitive function in mice with the disease. Alzheimer’s disease is thought to be ...

WASHINGTON, Oct. 14, 2025 – More than a million people around the world rely on cochlear implants (CIs) to hear. CI effectiveness is generally evaluated through speech recognition tests, and despite ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...